Blavatnik Biomedical Accelerator: Pre-Proposal Deadline
Date and Time
Blavatnik Biomedical AcceleratorDeadline: November 27, 2018 (pre-proposal); April 10, 2019 (full proposal)Award Amount: $100,000 over one year (Pilot Grants); $300,000 over two years (Development Grants)Eligible Applicants: Anyone with rights as a principal investigator (PI), whose employer is Harvard University and who has an obligation to assign intellectual property (IP) rights to Harvard, is eligible to apply.
The Blavatnik Biomedical Accelerator at Harvard University supports faculty in the performance and commercialization of applied life sciences research. The Accelerator provides funding and other support to help faculty validate their nascent technologies and identify potential industry partners to advance these technologies to the marketplace. The Accelerator is designed to accommodate projects of varying magnitude, as appropriate, and its primary goal is to advance technologies to the point where additional funding from industry and/or technology transfer is achieved. Supported projects have included therapeutics, diagnostics/biomarkers, instruments, and other biomedical technologies.
Accelerator awards will be made in two categories: Pilot Grants and Development Grants. Within the established budgetary parameters, projects will be funded at the level deemed necessary to achieve the proposed research objectives.
- Pilot Grant awards will be funded at a maximum of $100k for a period of up to 12 months. Pilot Grants are intended to support proof-of-concept activities that (if successful) would establish a basis for a subsequent Development Grant proposal.
- Development Grants will be funded at a maximum of $300k for a period of up to 24 months. Development Grants are expected to generate partnerable technology within the proposed timeframe.